Advertisement

Prostatitis and Male Chronic Pelvic Pain Syndrome

  • J. Curtis Nickel
Chapter
Part of the Springer Specialist Surgery Series book series (SPECIALIST)

Abstract

Our management of the clinical prostatitis syndromes has evolved significantly from the days of organ centric therapy for prostate infection and inflammation. It was only a decade or so ago when prostatitis seemed easy to understand and for the most part simple to manage. Traditionally, prostatitis involved acute or chronic inflammation of the prostate gland, either bacterial or nonspecific. Our treatment lay then, in eradicating offending organisms and reducing inflammation. Despite new and improved antimicrobials and anti-inflammatories, we realize that the prevalence and burden of prostatitis is as bad today as it was before these pharmacological agents were even discovered.1 Physicians have become discouraged and patients frustrated by our lack of clinical success. The good news is that our improved understanding of the etiology, pathogenesis, and epidemiology of the prostatitis syndromes has given us the tools to help the majority of patients who have failed our traditional approach of antibiotics and anti-inflammatories.2,3 This chapter will present important epidemiological data, explain our new understanding of the etiological processes involved, help classify and diagnose patients, outline the new evidence from clinical treatment trials and finally give the reader a blueprint for a therapeutic algorithm that works in clinical practice.

Keywords

Interstitial Cystitis Pelvic Pain Syndrome Randomize Placebo Control Trial Chronic Pelvic Pain Syndrome Alpha Blocker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Nickel JC. The three A’s of chronic prostatitis therapy; antibiotics, alpha-blockers, and anti-inflammatories: what is the evidence? BJU Int. 2004;94:1230-1233PubMedCrossRefGoogle Scholar
  2. 2.
    Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med. 2006;355: 1690-1698PubMedCrossRefGoogle Scholar
  3. 3.
    Nickel JC. Chronic prostatitis/chronic pelvic pain syndrome: a decade of change. AUA. 2006;25: 309-316Google Scholar
  4. 4.
    Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236-237PubMedCrossRefGoogle Scholar
  5. 5.
    Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of urinary symptoms and health status among men. Urology. 1998;51:578-584PubMedCrossRefGoogle Scholar
  6. 6.
    McNaughton-Collins M, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002; 167: 1363-1366CrossRefGoogle Scholar
  7. 7.
    Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study employing the NIH-chronic prostatitis symptom index (NIH-CPSI). J Urol. 2001;165:842–845PubMedCrossRefGoogle Scholar
  8. 8.
    McNaughton-Collins M, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159: 1224-1228CrossRefGoogle Scholar
  9. 9.
    Moon TD, Hagen L, Heisey DM. Urinary symptomatology in younger men. Urology. 1997;50:700-703PubMedCrossRefGoogle Scholar
  10. 10.
    Roberts RO, Jacobson DJ, Girman CJ, et al. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168:2467-2471PubMedCrossRefGoogle Scholar
  11. 11.
    Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, et al. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community. J Urol. 2005;174:2319PubMedCrossRefGoogle Scholar
  12. 12.
    McNaughton-Collins M, Joyce GF, Wise M, et al. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. In: Litwin MS, Saigal CS, et al., eds. Urologic Diseases in America. Washington, DC: U.S. Government Publishing Office; 2007:9-41Google Scholar
  13. 13.
    Wenninger K, Heiman JR, Rothman I, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996;155:965-968PubMedCrossRefGoogle Scholar
  14. 14.
    McNaughton-Collins M, Pontari MA, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Int Med. 2001;16:656-662CrossRefGoogle Scholar
  15. 15.
    Tripp DA, Nickel JC, Landis JR, et al. Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU Int. 2004;94:1279-1282PubMedCrossRefGoogle Scholar
  16. 16.
    Tripp DA, Nickel JC, Wang Y, et al. Catastrophizing and Pain-Contingent Rest Predict Patient Adjustment in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Pain. 2006;7:697-708PubMedCrossRefGoogle Scholar
  17. 17.
    Nickel JC, Tripp DA, Chuai S, et al. Psychosocial parameters impact quality of life in men diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). BJU Int. 2007;101:59-64PubMedGoogle Scholar
  18. 18.
    Calhoun EA, McNaughton Collins M, Pontari MA, et al. Chronic Prostatitis Collaborative Research Network. The economic impact of chronic prostatitis. Arch Intern Med. 2004;164:1231-1236PubMedCrossRefGoogle Scholar
  19. 19.
    Neal DE Jr. Treatment of acute prostatitis. In: Nickel JC, ed. Textbook of Prostatitis. Oxford: ISIS Medical Media Ltd.; 1999:279-284Google Scholar
  20. 20.
    Nickel JC, Moon T. Chronic bacterial prostatitis: an evolving clinical enigma. Urology. 2005;66:2-8PubMedCrossRefGoogle Scholar
  21. 21.
    Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170:818-822PubMedCrossRefGoogle Scholar
  22. 22.
    Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172:839-845PubMedCrossRefGoogle Scholar
  23. 23.
    Nickel JC. Inflammatory conditions of the male genitourinary tract: prostatitis and related conditions, orchitis, and epididymitis. In: Walsh P et al., eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: W. B. Saunders Company; 2006:330-370Google Scholar
  24. 24.
    Meares EM Jr, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492-518PubMedGoogle Scholar
  25. 25.
    McNaughton-Collins M, Fowler EH, Elliott DB, et al. Diagnosing and treating chronic prostatitis: do urologists use the 4-glass test? Urology. 2000;55:403-407PubMedCrossRefGoogle Scholar
  26. 26.
    Nickel JC. The Pre and Post Massage Test (PPMT): a simple screen for prostatitis. Tech Urol. 1997;3:38-43PubMedGoogle Scholar
  27. 27.
    Nickel JC, Shoskes D, Wang Y, et al. How does the pre- and post- massage test (PPMT) 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176:119-124PubMedCrossRefGoogle Scholar
  28. 28.
    Litwin MS, McNaughton-Collins M, Fowler FJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol. 1999;162:369-375PubMedCrossRefGoogle Scholar
  29. 29.
    Nickel JC, McNaughton-Collins M, Litwin SM. Development and use of a validated outcome measure for prostatitis. J Clin Outcomes Manag. 2001;8:30-37Google Scholar
  30. 30.
    Propert KJ, Litwin MS, Wang Y, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006; 15: 299-305PubMedCrossRefGoogle Scholar
  31. 31.
    Nickel JC. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2000;60:20-23. Suppl 6ACrossRefGoogle Scholar
  32. 32.
    Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) study. J Urol. 2002;168:1048-1053PubMedCrossRefGoogle Scholar
  33. 33.
    Shoskes DA. Use of antibiotics in chronic prostatitis syndromes. Can J Urol. 2001;8:24-28PubMedGoogle Scholar
  34. 34.
    Naber KJ. Antibiotic treatment of chronic bacterial prostatitis. In: Nickel JC, ed. Textbook of Prostatitis. Oxford: ISIS Medical Media Ltd.; 1999:283-292Google Scholar
  35. 35.
    Nickel JC, Weidner W. Chronic prostatitis: current concepts in antimicrobial therapy. Infect Urol. 2000;13:S22-S29Google Scholar
  36. 36.
    Bjerklund Johansen T, Gruneberg RN, Guibert J, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol. 1998;34: 457-466PubMedCrossRefGoogle Scholar
  37. 37.
    Shoskes DA, Zeitlin SI. Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate Cancer Prostatic Dis. 1999;2:159-162PubMedCrossRefGoogle Scholar
  38. 38.
    Nickel JC, Alexander R, Anderson R, et al. Prostatitis unplugged: prostate massage revisited. Tech Urol. 1999;5:1-7PubMedGoogle Scholar
  39. 39.
    Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 1999;159:883-887CrossRefGoogle Scholar
  40. 40.
    Kirby RS. Surgical considerations in the management of prostatitis. In: Nickel JC, ed. Textbook of Prostatitis. Oxford: ISIS Medical Media Ltd.; 1999:346-364Google Scholar
  41. 41.
    Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol. 2001;165:1539-1544PubMedCrossRefGoogle Scholar
  42. 42.
    Nickel JC, Xiang J. Clinical significance of non-traditional uropathogens in the management of chronic prostatitis. J Urol. 2008;179:1391-1395PubMedCrossRefGoogle Scholar
  43. 43.
    Nickel JC, Downey J, Clark J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62:614-617PubMedCrossRefGoogle Scholar
  44. 44.
    Alexander RB, Propert KJ, Schaeffer AJ, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann Int Med. 2004;141:581-589PubMedGoogle Scholar
  45. 45.
    Nickel JC, Pontari M, Moon T, et al. A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003;169:1401-1405PubMedCrossRefGoogle Scholar
  46. 46.
    Nickel JC, Forrest JB, Tomera K, et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo-controlled study. J Urol. 2005;173:1252-1255PubMedCrossRefGoogle Scholar
  47. 47.
    Cheah PY, Liong ML, Yuen KH, et al. Terazosin therapy for chronic prostatitis/ chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol. 2003;169:592-596PubMedCrossRefGoogle Scholar
  48. 48.
    Tugcu V, Tasci AI, Fazlioglu A, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol. 2007;51:1113-1118PubMedCrossRefGoogle Scholar
  49. 49.
    Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double-blind trial. J Urol. 2004;171:1594-1597PubMedCrossRefGoogle Scholar
  50. 50.
    Mehik A, Alas P, Nickel JC, et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology. 2003;62:425-429PubMedCrossRefGoogle Scholar
  51. 51.
    Yang G, Wei Q, Li H, et al. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials. J Androl. 2006;27(6): 847-852PubMedCrossRefGoogle Scholar
  52. 52.
    Mishra VC, Browne J, Emberton M. Role of alpha-blockers in type III prostatitis: a systemic review of the literature. J Urol. 2007;177(1):25-30PubMedCrossRefGoogle Scholar
  53. 53.
    Nickel JC, Krieger J, McNaughton-Collins M, et al. Effect of Alfuzosin on Symptoms in Men with Chronic Prostatitis / Chronic Pelvic Pain Syndrome. NEJM 2008; 359(25):2663-2673, 2008Google Scholar
  54. 54.
    Nickel JC, Downey J, Pontari MA, et al. Randomized placebo-controlled, multi-center study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis). BJU Int. 2004;93:991-995PubMedCrossRefGoogle Scholar
  55. 55.
    Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo control trial. Urology. 1999;54:960-963PubMedCrossRefGoogle Scholar
  56. 56.
    Shoskes DA, Nickel JC, Rackley RR, Pontari MA. Clinical Phenotyping in Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Interstitial Cystitis: A Management Strategy for Urologic Chronic Pelvic Pain Syndromes. Prostate Cancer and Prostatic Diseases 2009;12:177-83Google Scholar
  57. 57.
    Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical Phenotyping of Chronic Prostatitis/Chronic Pelvic Pain Patients and Correlation with Symptom Severity, Urol 2009;73:538-543Google Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  • J. Curtis Nickel
    • 1
  1. 1.Department of Urology, CIHR Canada Research Chair in Urologic Pain and InflammationQueen’s University, Kingston General HospitalKingstonCanada

Personalised recommendations